Publication: Antibody evasion by the P.1 strain of SARS-CoV-2
Issued Date
2021-05-27
Resource Type
ISSN
10974172
00928674
00928674
Other identifier(s)
2-s2.0-85104114261
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cell. Vol.184, No.11 (2021), 2939-2954.e9
Suggested Citation
Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, Chang Liu, Alexander J. Mentzer, Helen M. Ginn, Yuguang Zhao, Helen M.E. Duyvesteyn, Aekkachai Tuekprakhon, Rungtiwa Nutalai, Beibei Wang, César López-Camacho, Jose Slon-Campos, Thomas S. Walter, Donal Skelly, Sue Ann Costa Clemens, Felipe Gomes Naveca, Valdinete Nascimento, Fernanda Nascimento, Cristiano Fernandes da Costa, Paola Cristina Resende, Alex Pauvolid-Correa, Marilda M. Siqueira, Christina Dold, Robert Levin, Tao Dong, Andrew J. Pollard, Julian C. Knight, Derrick Crook, Teresa Lambe, Elizabeth Clutterbuck, Sagida Bibi, Amy Flaxman, Mustapha Bittaye, Sandra Belij-Rammerstorfer, Sarah C. Gilbert, Miles W. Carroll, Paul Klenerman, Eleanor Barnes, Susanna J. Dunachie, Neil G. Paterson, Mark A. Williams, David R. Hall, Ruben J.G. Hulswit, Thomas A. Bowden, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart, Gavin R. Screaton Antibody evasion by the P.1 strain of SARS-CoV-2. Cell. Vol.184, No.11 (2021), 2939-2954.e9. doi:10.1016/j.cell.2021.03.055 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/76177
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Antibody evasion by the P.1 strain of SARS-CoV-2
Author(s)
Wanwisa Dejnirattisai
Daming Zhou
Piyada Supasa
Chang Liu
Alexander J. Mentzer
Helen M. Ginn
Yuguang Zhao
Helen M.E. Duyvesteyn
Aekkachai Tuekprakhon
Rungtiwa Nutalai
Beibei Wang
César López-Camacho
Jose Slon-Campos
Thomas S. Walter
Donal Skelly
Sue Ann Costa Clemens
Felipe Gomes Naveca
Valdinete Nascimento
Fernanda Nascimento
Cristiano Fernandes da Costa
Paola Cristina Resende
Alex Pauvolid-Correa
Marilda M. Siqueira
Christina Dold
Robert Levin
Tao Dong
Andrew J. Pollard
Julian C. Knight
Derrick Crook
Teresa Lambe
Elizabeth Clutterbuck
Sagida Bibi
Amy Flaxman
Mustapha Bittaye
Sandra Belij-Rammerstorfer
Sarah C. Gilbert
Miles W. Carroll
Paul Klenerman
Eleanor Barnes
Susanna J. Dunachie
Neil G. Paterson
Mark A. Williams
David R. Hall
Ruben J.G. Hulswit
Thomas A. Bowden
Elizabeth E. Fry
Juthathip Mongkolsapaya
Jingshan Ren
David I. Stuart
Gavin R. Screaton
Daming Zhou
Piyada Supasa
Chang Liu
Alexander J. Mentzer
Helen M. Ginn
Yuguang Zhao
Helen M.E. Duyvesteyn
Aekkachai Tuekprakhon
Rungtiwa Nutalai
Beibei Wang
César López-Camacho
Jose Slon-Campos
Thomas S. Walter
Donal Skelly
Sue Ann Costa Clemens
Felipe Gomes Naveca
Valdinete Nascimento
Fernanda Nascimento
Cristiano Fernandes da Costa
Paola Cristina Resende
Alex Pauvolid-Correa
Marilda M. Siqueira
Christina Dold
Robert Levin
Tao Dong
Andrew J. Pollard
Julian C. Knight
Derrick Crook
Teresa Lambe
Elizabeth Clutterbuck
Sagida Bibi
Amy Flaxman
Mustapha Bittaye
Sandra Belij-Rammerstorfer
Sarah C. Gilbert
Miles W. Carroll
Paul Klenerman
Eleanor Barnes
Susanna J. Dunachie
Neil G. Paterson
Mark A. Williams
David R. Hall
Ruben J.G. Hulswit
Thomas A. Bowden
Elizabeth E. Fry
Juthathip Mongkolsapaya
Jingshan Ren
David I. Stuart
Gavin R. Screaton
Other Contributor(s)
Siriraj Hospital
NIHR Oxford Biomedical Research Centre
Oxford University Hospitals NHS Foundation Trust
Texas A&M College of Veterinary Medicine & Biomedical Sciences
Public Health England
Diamond Light Source
Worthing Hospital
University of Oxford
Fundacao Oswaldo Cruz
Fiocruz Amazônia
Nuffield Department of Medicine
University of Oxford Medical Sciences Division
Instruct-ERIC
Fundação de Vigilância em Saúde do Amazonas
NIHR Oxford Biomedical Research Centre
Oxford University Hospitals NHS Foundation Trust
Texas A&M College of Veterinary Medicine & Biomedical Sciences
Public Health England
Diamond Light Source
Worthing Hospital
University of Oxford
Fundacao Oswaldo Cruz
Fiocruz Amazônia
Nuffield Department of Medicine
University of Oxford Medical Sciences Division
Instruct-ERIC
Fundação de Vigilância em Saúde do Amazonas
Abstract
Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates. However, new strains have emerged with multiple mutations, including P.1 from Brazil, B.1.351 from South Africa, and B.1.1.7 from the UK (12, 10, and 9 changes in the spike, respectively). All have mutations in the ACE2 binding site, with P.1 and B.1.351 having a virtually identical triplet (E484K, K417N/T, and N501Y), which we show confer similar increased affinity for ACE2. We show that, surprisingly, P.1 is significantly less resistant to naturally acquired or vaccine-induced antibody responses than B.1.351, suggesting that changes outside the receptor-binding domain (RBD) impact neutralization. Monoclonal antibody (mAb) 222 neutralizes all three variants despite interacting with two of the ACE2-binding site mutations. We explain this through structural analysis and use the 222 light chain to largely restore neutralization potency to a major class of public antibodies.